Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
SAG - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Congenital Stationary Night Blindness Panel Invitae United States | 36 | 22 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Retinitis Pigmentosa, autosomal recessive and X-linked Amplexa Genetics Amplexa Genetics A/S Denmark | 2 | 65 |
|
Congenital Stationary Night Blindness Amplexa Genetics Amplexa Genetics A/S Denmark | 1 | 15 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Congenital Stationary Night Blindness Panel PreventionGenetics, part of Exact Sciences United States | 18 | 17 |
|
PreventionGenetics, part of Exact Sciences United States | 91 | 82 |
|
Autosomal Recessive Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 62 | 60 |
|
Oguchi Disease and Retinitis Pigmentosa (RP47) via the SAG Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
SAG Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
SAG Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
SAG Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.